Literature DB >> 21804543

FOXO1 is an essential regulator of pluripotency in human embryonic stem cells.

Xin Zhang1, Safak Yalcin, Dung-Fang Lee, Tsung-Yin J Yeh, Seung-Min Lee, Jie Su, Sathish Kumar Mungamuri, Pauline Rimmelé, Marion Kennedy, Rani Sellers, Markus Landthaler, Thomas Tuschl, Nai-Wen Chi, Ihor Lemischka, Gordon Keller, Saghi Ghaffari.   

Abstract

Pluripotency of embryonic stem cells (ESCs) is defined by their ability to differentiate into three germ layers and derivative cell types and is established by an interactive network of proteins including OCT4 (also known as POU5F1; ref. 4), NANOG (refs 5, 6), SOX2 (ref. 7) and their binding partners. The forkhead box O (FoxO) transcription factors are evolutionarily conserved regulators of longevity and stress response whose function is inhibited by AKT protein kinase. FoxO proteins are required for the maintenance of somatic and cancer stem cells; however, their function in ESCs is unknown. We show that FOXO1 is essential for the maintenance of human ESC pluripotency, and that an orthologue of FOXO1 (Foxo1) exerts a similar function in mouse ESCs. This function is probably mediated through direct control by FOXO1 of OCT4 and SOX2 gene expression through occupation and activation of their respective promoters. Finally, AKT is not the predominant regulator of FOXO1 in human ESCs. Together these results indicate that FOXO1 is a component of the circuitry of human ESC pluripotency. These findings have critical implications for stem cell biology, development, longevity and reprogramming, with potentially important ramifications for therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21804543      PMCID: PMC4053529          DOI: 10.1038/ncb2293

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  53 in total

Review 1.  Naive and primed pluripotent states.

Authors:  Jennifer Nichols; Austin Smith
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

Review 2.  Integrating opposing signals toward Forkhead box O.

Authors:  Maaike C W van den Berg; Boudewijn M T Burgering
Journal:  Antioxid Redox Signal       Date:  2010-10-14       Impact factor: 8.401

Review 3.  Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned?

Authors:  Xin Zhang; Maité Rielland; Safak Yalcin; Saghi Ghaffari
Journal:  Curr Drug Targets       Date:  2011-08       Impact factor: 3.465

4.  ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice.

Authors:  Safak Yalcin; Dragan Marinkovic; Sathish Kumar Mungamuri; Xin Zhang; Wei Tong; Rani Sellers; Saghi Ghaffari
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

5.  TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

Authors:  Kazuhito Naka; Takayuki Hoshii; Teruyuki Muraguchi; Yuko Tadokoro; Takako Ooshio; Yukio Kondo; Shinji Nakao; Noboru Motoyama; Atsushi Hirao
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

6.  Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.

Authors:  Kazuyuki Yamagata; Hiroaki Daitoku; Yuta Takahashi; Kana Namiki; Koji Hisatake; Koichiro Kako; Hidehito Mukai; Yoshitoshi Kasuya; Akiyoshi Fukamizu
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

7.  Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells.

Authors:  Safak Yalcin; Xin Zhang; Julia P Luciano; Sathish Kumar Mungamuri; Dragan Marinkovic; Cécile Vercherat; Abby Sarkar; Marcos Grisotto; Reshma Taneja; Saghi Ghaffari
Journal:  J Biol Chem       Date:  2008-04-18       Impact factor: 5.157

8.  FoxO3 regulates neural stem cell homeostasis.

Authors:  Valérie M Renault; Victoria A Rafalski; Alex A Morgan; Dervis A M Salih; Jamie O Brett; Ashley E Webb; Saul A Villeda; Pramod U Thekkat; Camille Guillerey; Nicholas C Denko; Theo D Palmer; Atul J Butte; Anne Brunet
Journal:  Cell Stem Cell       Date:  2009-11-06       Impact factor: 24.633

9.  Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity.

Authors:  Tobias B Dansen; Lydia M M Smits; Miranda H van Triest; Peter L J de Keizer; Dik van Leenen; Marian Groot Koerkamp; Anna Szypowska; Amanda Meppelink; Arjan B Brenkman; Junji Yodoi; Frank C P Holstege; Boudewijn M T Burgering
Journal:  Nat Chem Biol       Date:  2009-08-02       Impact factor: 15.040

10.  mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion.

Authors:  Jae Y Lee; Daisuke Nakada; Omer H Yilmaz; Zuzana Tothova; Nancy M Joseph; Megan S Lim; D Gary Gilliland; Sean J Morrison
Journal:  Cell Stem Cell       Date:  2010-11-05       Impact factor: 24.633

View more
  121 in total

1.  Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency.

Authors:  Dung-Fang Lee; Jie Su; Ana Sevilla; Julian Gingold; Christoph Schaniel; Ihor R Lemischka
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

Review 2.  FOXO3: A Major Gene for Human Longevity--A Mini-Review.

Authors:  Brian J Morris; Donald Craig Willcox; Timothy A Donlon; Bradley J Willcox
Journal:  Gerontology       Date:  2015-03-28       Impact factor: 5.140

3.  FoxO3a contributes to the reprogramming process and the differentiation of induced pluripotent stem cells.

Authors:  Yongxiang Wang; Changhai Tian; Jialin C Zheng
Journal:  Stem Cells Dev       Date:  2013-08-09       Impact factor: 3.272

4.  Functional screen reveals essential roles of miR-27a/24 in differentiation of embryonic stem cells.

Authors:  Yanni Ma; Nan Yao; Guang Liu; Lei Dong; Yufang Liu; Meili Zhang; Fang Wang; Bin Wang; Xueju Wei; He Dong; Lanlan Wang; Shaowei Ji; Junwu Zhang; Yangming Wang; Yue Huang; Jia Yu
Journal:  EMBO J       Date:  2014-12-17       Impact factor: 11.598

Review 5.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

Review 6.  Paths to stemness: building the ultimate antitumour T cell.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

7.  FOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH.

Authors:  Zhilin Liu; Diego H Castrillon; Wei Zhou; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2013-01-15

8.  FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression.

Authors:  Paraskevi Charitou; Maria Rodriguez-Colman; Johan Gerrits; Miranda van Triest; Marian Groot Koerkamp; Marten Hornsveld; Frank Holstege; Nanda M Verhoeven-Duif; Boudewijn M T Burgering
Journal:  EMBO Rep       Date:  2015-02-03       Impact factor: 8.807

9.  miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.

Authors:  Zhiju Zhao; Limei Qin; Shu Li
Journal:  Tumour Biol       Date:  2015-11-17

10.  FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis.

Authors:  Xin Zhang; Genís Campreciós; Pauline Rimmelé; Raymond Liang; Safak Yalcin; Sathish Kumar Mungamuri; Jeffrey Barminko; Valentina D'Escamard; Margaret H Baron; Carlo Brugnara; Dmitri Papatsenko; Stefano Rivella; Saghi Ghaffari
Journal:  Am J Hematol       Date:  2014-07-22       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.